Sartorius, founded in 1870, stands as a prominent international player in the realm of biopharma research and manufacturing. Known for their slogan, "A Trusted Partner of Biopharma Research and Manufacturing | #SimplifyingProgress," the company seeks to streamline processes from drug discovery to manufacturing, ultimately broadening access to better medicine.
Sartorius's product offerings cater to two primary customer segments: laboratories in pharmaceutical and biopharmaceutical companies, along with academic research institutes. Their innovative laboratory instruments and consumables are pivotal for research and quality control. Furthermore, their extensive bioprocess product portfolio, with an emphasis on single-use solutions, facilitates the safe, rapid, and economic production of biotech medications, vaccines, and cell and gene therapies.
Headquartered in Göttingen, Germany, Sartorius boasts a robust global footprint, with over 60 production and sales sites worldwide, and a workforce of more than 14,000 employees across 110+ countries. With recent sales revenue reaching around 3.5 billion euros in 2025, the company frequently enhances its portfolio through strategic acquisitions of complementary technologies, reinforcing its position in the market.